Begin typing your search...
FDA okays Parry’s microalgae facility
Parry Nutraceuticals (a division of EID Parry and part of the Murugappa Group) has received the US Food and Drug Administration (US-FDA) approval for its India facility for organic microalgae cultivation and processing.
The fully organic, 130 acres – 600 TPA facility, located in Oonaiyur, Pudukkottai, has received the Establishment Inspection Report (EIR) from the US-FDA post an inspection of the facility in July 2016.
Muthu Murugappan, Business Head, Parry Nutraceuticals, said, “We are a preferred supplier of micro-algal health supplements for several nutraceutical brands in over 35 countries. This approval will enhance our reputation as a leader in micro-algal technology.”
The company is also stepping up its new product development (NPD) efforts to meet increasing demand for value-added products based on microalgae. He added, “Some products we will bring to the market over two years include Organic Chlorella, Spirulina Granules, CO2 Extracted Lutein and Algal Beta Glucan, to name a few. New areas under development include vegan algal proteins, chlorophyll and algae (vegan) omega-3s.”